Managing Directors Vetter Pharma-Fertigung GmbH & Co. KG

Max Horn                                                                             

Max Horn has been the Managing Director of Vetter Pharma-Fertigung GmbH & Co. KG since November, 2002. He joined the company's accounting department in 1981 after graduating from the German Academy of Business and Administration in Ravensburg. Four years later, he became Representative Accounting Director. In 1993, he took up the position of Director of Controlling. Horn was promoted to Executive Director, Financial Affairs, and became a member of the board of the Vetter Group in 2000. In the same year, he participated in the Senior Executive Program of the eminent Columbia Business School.

Thomas Otto

Thomas Otto assumed the position of Managing Director at Vetter Pharma-Fertigung GmbH & Co. KG on December, 2002. Otto graduated from the Vocational School in Stuttgart with an engineering degree in packaging technology and print processing in 1990. He was then employed with Vetter Pharma-Fertigung GmbH & Co. KG, where he worked first as a project engineer. From 1995 to 1999, he managed of the department of Packaging Materials Development. From 2000 to 2002, he headed Vetter`s department of Research & Development.

Peter Soelkner

Peter Soelkner has been a Managing Director at Vetter Pharma-Fertigung GmbH & Co. KG since June 2008. He has been appointed Managing director at Vetter Pharma International GmbH effective April 1, 2009. Peter Soelkner graduated from the University of Dortmund, Germany, in 1992 with a degree in Chemical Engineering and from the Columbia University, New York, in 2001 with an MBA. His professional life includes international positions in Germany and North America at Sartorius AG and Sartorius North America Inc., where he worked in R&D, Marketing, Key Account Management and General Management. From 2003 to 2007, Peter Soelkner managed the Key Account Program and the global end-to-end supply chain at Vetter. Prior to joining Vetter a second time, he was Vice President of Global KAM at Sartorius Stedim Biotech (USA).